Asen Bagashev
Io Therapeutics (United States)
ORCID: 0000-0001-9900-8106Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “Modulation of CD22 Protein Expression in Childhood Leukemia by Pervasive Splicing Aberrations: Implications for CD22-Directed Immunotherapies”.
Elisabeth Gillespie, Ammar S. Naqvi, Katharina E. Hayer, Zhiwei Ang, Manuel Torres-Diz +17 more
Anella Yahiaoui, Patrick A. Brown, Lisa M Niswander, Asen Bagashev, Min Wang +4 more
Katharina E. Hayer, Ammar S. Naqvi, Sisi Zheng, Scarlett Y. Yang, Derek Oldridge +14 more
Lisa M Niswander, Asen Bagashev, Joseph P. Loftus, Savannah Ross, Robert Chen +7 more
Maryline Santerre, Charles Allen, Sterling P. Arjona, Ruma Mukerjee, Jin Park +6 more
Gerald Wertheim, Joseph P. Loftus, Daniel Blumenthal, Anne W. Lehman, Yong Li +8 more
Maryline Santerre, Charles Allen, Sterling P. Arjona, Carmen Merali, Ruma Mukerjee +10 more